Back
Amplify Weight Loss Drug & Treatment ETF Stock Price Chart

Could BOXABL Be the Tesla of Housing?
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.
Sell
37
THNR
Amplify Weight Loss Drug & Treatment ETF
Last Price:
$22.06
Seasonality Move:
--
7 Day Trial
ALL ACCESS PASS
$
7

Is the Traditional House Obsolete?
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and THNR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Amplify Weight Loss Drug & Treatment ETF Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 21.63 | Sell |
20-day SMA: | 21.68 | Sell |
50-day SMA: | 21.29 | Buy |
200-day SMA: | 23.91 | Sell |
8-day EMA: | 21.66 | Sell |
20-day EMA: | 21.53 | Sell |
50-day EMA: | 21.59 | Sell |
200-day EMA: | 23.56 | Sell |
Amplify Weight Loss Drug & Treatment ETF Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.14 | Buy |
Relative Strength Index (14 RSI): | 50.23 | Buy |
Chaikin Money Flow: | 3940 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.88 - 22.02) | Buy |
Bollinger Bands (100): | (20.98 - 23.2) | Sell |
Amplify Weight Loss Drug & Treatment ETF Technical Analysis
May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | May 22 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Amplify Weight Loss Drug & Treatment ETF Stock
Is Amplify Weight Loss Drug & Treatment ETF Stock a Buy?
-
Amplify Weight Loss Drug & Treatment ETF share price is 21.50 while THNR 8-day simple moving average is 21.63, which is a Sell signal.
-
The stock price of THNR is 21.50 while Amplify Weight Loss Drug & Treatment ETF 20-day SMA is 21.68, which makes it a Sell.
-
Amplify Weight Loss Drug & Treatment ETF 50-day simple moving average is 21.29 while THNR share price is 21.50, making it a Buy technically.
-
THNR stock price is 21.50 and Amplify Weight Loss Drug & Treatment ETF 200-day simple moving average is 23.91, creating a Sell signal.
THNR Technical Analysis vs Fundamental Analysis
Sell
37
Amplify Weight Loss Drug & Treatment ETF (THNR)
is a Sell
Is Amplify Weight Loss Drug & Treatment ETF a Buy or a Sell?
-
Amplify Weight Loss Drug & Treatment ETF stock is rated a SellThe current Amplify Weight Loss Drug & Treatment ETF [THNR] share price is $21.50. The Score for THNR is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Amplify Weight Loss Drug & Treatment ETF Stock Info
Market Cap:
0
Price in USD:
21.50
Share Volume:
3.9K
Amplify Weight Loss Drug & Treatment ETF 52-Week Range
52-Week High:
28.19
52-Week Low:
18.56
Sell
37
Amplify Weight Loss Drug & Treatment ETF (THNR)
is a Sell
Amplify Weight Loss Drug & Treatment ETF Share Price Forecast
-
What is the Amplify Weight Loss Drug & Treatment ETF stock price today?The Amplify Weight Loss Drug & Treatment ETF stock price is 21.50 USD today.
-
Will THNR stock go up or go down?Amplify Weight Loss Drug & Treatment ETF> share price is forecast to RISE/FALL based on technical indicators
-
Is Amplify Weight Loss Drug & Treatment ETF overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Amplify Weight Loss Drug & Treatment ETF is overvalued.
Is Amplify Weight Loss Drug & Treatment ETF Stock a Buy?
-
Amplify Weight Loss Drug & Treatment ETF share price is 21.50 while THNR 8-day exponential moving average is 21.66, which is a Sell signal.
-
The stock price of THNR is 21.50 while Amplify Weight Loss Drug & Treatment ETF 20-day EMA is 21.53, which makes it a Sell.
-
Amplify Weight Loss Drug & Treatment ETF 50-day exponential moving average is 21.59 while THNR share price is 21.50, making it a Sell technically.
-
THNR stock price is 21.50 and Amplify Weight Loss Drug & Treatment ETF 200-day simple moving average is 23.56, creating a Sell signal.
Technical Analysis of Amplify Weight Loss Drug & Treatment ETF
Should I short Amplify Weight Loss Drug & Treatment ETF stock?
-
THNR Moving Average Covergence Divergence (MACD) indicator is 0.14, suggesting Amplify Weight Loss Drug & Treatment ETF is a Buy
-
Amplify Weight Loss Drug & Treatment ETF Relative Strength Index (RSI) is 50.23, which suggest Amplify Weight Loss Drug & Treatment ETF is overbought
-
The Bollinger Bands (25) for Amplify Weight Loss Drug & Treatment ETF is (20.88 - 22.02), which suggest Amplify Weight Loss Drug & Treatment ETF is a Sell
-
The Bollinger Bands (100) for Amplify Weight Loss Drug & Treatment ETF is (20.98 - 23.2), which suggest Amplify Weight Loss Drug & Treatment ETF is a Sell
* Amplify Weight Loss Drug & Treatment ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.